Sign up for our Newsletter

Whiz Cleancatch Midstream

Whiz Cleancatch Midstream is a midstream urine sample collection device, designed and clinically proven to make urine sample collection automatic, patient and staff independent, delivering a clinically proven, significantly superior and more accurate sample, which is collected more hygienically, easier, cleaner, faster and cheaper than anything currently available.

The Whiz Cleancatch Midstream "is not simply a funnel, but incorporates a flow-sensitive channel and diverter that, using urodynamic principles, excludes the initial low-flow portion of the urinary stream, thus discarding the contaminated early stream volume, and automatically collects the midstream volume without interrupting the stream."

The Whiz Cleancatch Midstream is a leap forward in technology and product design. While the equipment for the analysis of urine has improved dramtically the last 100 years, the method of collection has not changed. A fast modern machine is rendered useless if the quality of the sample is poor. And currently urine samples have a high inherent contamination rate as high as 56% amongst GP’s collected samples (Garcia et al). In large scale trials the Cleancatch has reduced this to 3­4%.

CLINICAL BENEFITS OF THE CLEANCATCH MIDSTREAM:

SIGNIFICANTLY REDUCES:

• General contamination in GP's surgeries by 73%****
• Heavy mixed growth by 60%*
• General contamination by 31%*
• Urine spillage by 41%*
• Re--test rates by 28%*

IMPROVES:

• Identification of UTIs by 6%*
• Number of clinically non-significant cultures by 5%*
• Quality of sample
• Accuracy of diagnosis
• Staff working conditions and practices

SATISFIED CLINICAL PROFESSIONALS

• It greatly reduces contact with urine
• No time consuming instruction need to be given
• Confidence in urine sample, whether given at home or in presence of doctor/nurse
• Standardises urine collection practice

PUBLIC & PRIVATE FINANCIAL BENEFITS OF THE CLEANCATCH MIDSTREAM:

The reduction in the number of re-tests and associated costs create considerable financial benefits to the healthcare provider. The potential savings to the NHS on microbiological samples alone would be a minimum of £23 million**, with total savings of some £40-60 million p.a. Whiting et al 2006 - a major NHS cost study gives (p.116) the cost of a urine test at £25.00 in GP environment and £100 plus in a hospital environment. At national average contamination rates of 31% and at a clinically proven 4% Cleancatch rate, this is a minimum saving of £15.84 per test from GP’s and £93.84 per test in the hospital environment when paying £1.12 per unit for the Cleancatch and only 7p for the non-sterile universal. *****

The Cleancatch results in lower staff costs in collection centres. Lower cleaning costs in both time and materials. Lower contamination rates mean: less time spent on microscopy, fewer full cultures, fewer direct sensitivity tests, less time spent analysing results. Fewer false positives. Better detection of UTIs. Less coldroom and bench space required. Faster, more accurate services.

REFERENCES:

* "A novel midstream urine collection device reduces contamination rates in urine cultures amongst women" Jackson et al - BJU Int. August 2005, 96 pp 360-364

** University of Oxford, Said Business School Health Economic Model - MBA Programme

*** Failure to comply could lead to medico/legal action. In 2003 the NHS paid £450M in claims and currently holds a provision of £8B for future claims. Professor Sir Ara Darzi - Synaptiq

**** "Improving the quality of mid-stream urine samples with a collection device" Dryden et al - Poster (ICAAC Program Committee Award), ICAAC Sept 2007, Chicago.

***** "Department of Health, Centre for Evidence based Purchasing Report #07004", January 2008